Infliximab: A Promising New Treatment Option for Ulcerated Necrobiosis Lipoidica

Letters| March 10 2003 Infliximab: A Promising New Treatment Option for Ulcerated Necrobiosis Lipoidica Subject Area: Dermatology , Immunology and Allergy Gerhard Kolde; Gerhard Kolde Department of Dermatology, Charité, Humboldt University of Berlin, and Search for other works by this author on: This Site PubMed Google Scholar J. Marcus Muche; J. Marcus Muche Department of Dermatology, Charité, Humboldt University of Berlin, and Search for other works by this author on: This Site PubMed Google Scholar Peter Schulze; Peter Schulze Department of Dermatology, Charité, Humboldt University of Berlin, and Search for other works by this author on: This Site PubMed Google Scholar Peter Fischer; Peter Fischer Department of Pneumology, Center for Lung Disease and Thoracic Surgery, Berlin, Germany Search for other works by this author on: This Site PubMed Google Scholar Jürgen Lichey Jürgen Lichey Department of Pneumology, Center for Lung Disease and Thoracic Surgery, Berlin, Germany Search for other works by this author on: This Site PubMed Google Scholar Dermatology (2003) 206 (2): 180–181. https://doi.org/10.1159/000068465 Article history Received: July 09 2002 Accepted: July 15 2002 Published Online: March 10 2003 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Gerhard Kolde, J. Marcus Muche, Peter Schulze, Peter Fischer, Jürgen Lichey; Infliximab: A Promising New Treatment Option for Ulcerated Necrobiosis Lipoidica. Dermatology 1 July 2003; 206 (2): 180–181. https://doi.org/10.1159/000068465 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsDermatology Search Advanced Search This content is only available via PDF. 2003Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Article PDF first page preview Close Modal You do not currently have access to this content.